Showing 921 - 940 results of 235,177 for search '(( 2 e decrease ) OR ( 10 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.13s Refine Results
  1. 921
  2. 922

    Data Sheet 1_Decreased cigarette smoking may partially explain the increased prevalence of antinuclear antibodies in the United States.pdf by Gregg E. Dinse (4500940)

    Published 2025
    “…High-titer antinuclear antibodies (ANA) are associated with autoimmune diseases, and ANA prevalence in the US increased between 1988 and 2012. Tobacco smoking decreased during those years while vaping of electronic cigarettes (e-cigarettes) increased after their introduction in 2007. …”
  3. 923

    T0 treatment significantly decreased soluble Aβ oligomers, but not amyloid plaque pathology in APP/E4/Abca1<sup>+/-</sup> mice. by Alexis Y. Carter (3798223)

    Published 2017
    “…N.S., not significant. <b>E,</b> T0 treatment significantly decreases Aβ oligomers in APP/E4/Abca1<sup>+/-</sup> mice. …”
  4. 924
  5. 925
  6. 926
  7. 927
  8. 928
  9. 929

    Top 10 gene ontologies with the lowest p-value. by Rizka Fatriani (17485787)

    Published 2024
    “…The stability of the protein-ligand complex resulting from docking was examined using molecular dynamics simulations, and we observed the best average root mean square deviation (RMSD) of 0.99 Å for PPARG with trans-3-indoleacrylic acid, which was lower than with the native ligand BRL (2.02 Å). Furthermore, the RMSD was 2.70 Å for EP300 and the native ligand 99E, and the lowest RMSD with the ligand (1R,9S)-5-[(E)-2-(4-Chlorophenyl)vinyl]-11-(5-pyrimidinylcarbonyl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one was 3.33 Å. …”
  10. 930
  11. 931
  12. 932
  13. 933
  14. 934
  15. 935

    Table_1_Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [18F]SDM-16.DOCX by Chao Zheng (728465)

    Published 2023
    “…In this study, we tested [<sup>18</sup>F]SDM-16, a novel metabolically stable SV2A PET imaging probe, in the transgenic APPswe/PS1dE9 (APP/PS1) mouse model of AD and age-matched wild-type (WT) mice at 12 months of age.…”
  16. 936
  17. 937
  18. 938
  19. 939
  20. 940